KP415 oral capsule + Placebo oral capsule
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedAbout KP415 oral capsule + Placebo oral capsule
KP415 oral capsule + Placebo oral capsule is a phase 3 stage product being developed by Zevra Therapeutics for ADHD. The current trial status is completed. This product is registered under clinical trial identifier NCT03292952. Target conditions include ADHD.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03292952 | Phase 3 | Completed |
Competing Products
20 competing products in ADHD